Active	Status	Sponsor type	Region	Phase	Filter
9 Active 14 Inactive 23 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

9 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Roux, Carel W Le
NCT03363581: Food Preference Following Bariatric Surgery	Completed	N/A	34	Europe	Food Preference	Imperial College London	Obesity	09/21	09/21
NCT05324241: Laxative Properties of Microencapsulated Lipid (Constipation Study)	Recruiting	N/A	31	Europe	Fat Microcapsules	University College Dublin	Constipation	04/23	04/23
NCT05074914: Unintentional Weight Loss After Oesophagectomy	Recruiting	N/A	64	Europe	oesophagectomy	University College Dublin	Oesophageal Cancer	06/23	06/23
NCT06135935: Postprandial Glucose Response Using Mass-Market No-Added-Sugar Ice Cream	Recruiting	N/A	12	RoW	No-added-sugar ice cream, Conventional products	Dasman Diabetes Institute	Type 2 Diabetes	12/23	01/24
α-MSH & T2DM, NCT06293664: Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes	Recruiting	N/A	13	RoW	α-MSH infusion, Placebo solutions	Dasman Diabetes Institute	Type 2 Diabetes Mellitus	04/24	04/24
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes	Suspended	N/A	320	Europe, US	Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham)	Fractyl Health Inc.	Type 2 Diabetes	06/25	01/26
NCT04595968: Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus	Completed	N/A	267	Europe, US	Vestal DM Active device, Lifestyle modification, Vestal DM Sham device	Neurovalens Ltd., University College Dublin, CS Lifescience, Clinical Trial Mentors	Type 2 Diabetes	08/24	08/24
VOYAGER, NCT06710587: Does Use of the Voy Program Improve Weight Loss Percentage and Other Health Outcomes in a Population Already Taking GLP/GIP-1RA Medication?	Not yet recruiting	N/A	470	NA	Voy Program	Menwell Limited, Lindus Health	Obesity, Weight Loss	04/26	04/27
BY-PLUS, NCT04432025: Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus	Recruiting	N/A	150	Europe	Bariatric surgery + goal directed medical therapy, Bariatric surgery	Imperial College London	Obesity, Type 2 Diabetes	04/27	08/27
Arimin, Mat
No trials found